Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Trachystemon orientalis (L.) D.Don is a perennial herb belonging to the Boraginaceae family, primarily found in the northern regions of Türkiye. It is widely consumed as food and utilized in traditional medicine for various ailments, including different types of cancer. Scientific studies have demonstrated that extracts and isolated compounds from T. orientalis exhibit significant antioxidant, anti-inflammatory, and cytoprotective properties. Furthermore, it has shown inhibitory effects on enzymes involved in lipid metabolism, such as pancreatic lipase and cholesterol esterase. Key active compounds identified include rosmarinic acid, β-sitosterol, danshensu, kaempferol 3-O-glucoside (astragalin), kaempferol 7-O-glucoside, globoidnan B, and rabdosiin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on trachystemon orientalis.